Treating the wheezing infant

被引：8

作者：

Covar, RA ^{[1
]}

Spahn, JD ^{[1
]}

机构：

[1] Natl Jewish Med & Res Ctr, Div Clin Immunol & Allergy, Dept Pediat, Denver, CO 80206 USA

来源：

PEDIATRIC CLINICS OF NORTH AMERICA | 2003年 / 50卷 / 03期

关键词：

D O I：

10.1016/S0031-3955(03)00051-8

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The management of infants and small children with asthma is a challenging task because of the many issues unique to this age group. The diagnosis of asthma is limited by inherent difficulties in obtaining objective measures of lung function and airway inflammation. Large prospective studies. need to be performed evaluating the impact of early pharmacologic intervention on the natural history of infantile asthma. Many areas needing investigation involve whicmedications to use, how best to deliver the medications, and how to monitor the response to treatment. Only a few medications have been approved for use in this population. Longterm studies evaluating available drugs such as inhaled glucocorticoids, long-acting beta-agonists, and the leukotriene-modifying agents in young children still need to be performed.

引用

页码：631 / +

页数：25

共 84 条

[11] The effect of inhaled fluticasone propionate in the treatment of young asthmatic children - A dose comparison study [J].

Bisgaard, H ;

Gillies, J ;

Groenewald, M ;

Maden, C .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) :126-131

[12] Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children [J].

Bisgaard, H ;

Nielsen, KG .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (01) :187-190

[13]

*BRIT THOR SOC, 1997, THORAX S1, V52, pS9

[14] A clinical index to define risk of asthma in young children with recurrent wheezing [J].

Castro-Rodríguez, JA ;

Holberg, CJ ;

Wright, AL ;

Martinez, FD .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (04) :1403-1406

[15]

*CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343

[16] LEUKOTRIENE RECEPTOR ANTAGONISTS AND BIOSYNTHESIS INHIBITORS - POTENTIAL BREAKTHROUGH IN ASTHMA THERAPY [J].

CHUNG, KF .

EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (07) :1203-1213

[17] PREVENTION OF VIRAL INDUCED ASTHMA ATTACKS USING INHALED BUDESONIDE [J].

CONNETT, G ;

LENNEY, W .

ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 68 (01) :85-87

[18] PREDNISOLONE AND SALBUTAMOL IN THE HOSPITAL TREATMENT OF ACUTE ASTHMA [J].

CONNETT, GJ ;

WARDE, C ;

WOOLER, E ;

LENNEY, W .

ARCHIVES OF DISEASE IN CHILDHOOD, 1994, 70 (03) :170-173

[19] NATURAL-HISTORY OF BRONCHIAL-ASTHMA IN CHILDHOOD - A PROSPECTIVE-STUDY FROM BIRTH UP TO 12-14 YEARS OF AGE [J].

CRONER, S ;

KJELLMAN, NIM .

ALLERGY, 1992, 47 (02) :150-157

[20] Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study [J].

deBlic, J ;

Delacourt, C ;

LeBourgeois, M ;

Mahut, B ;

Ostinelli, J ;

Caswell, C ;

Scheinmann, P .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (01) :14-20

← 1 2 3 4 5 6 7 8 9 →